Company News
Solara Pharma Rights Issue Second Final Call
Solara Active Pharma's Rights Issue Committee approved a Second & Final call of ₹112.50 per partly-paid Rights Share on March 24, 2026.
The call comprises ₹3.00 towards face value and ₹109.50 towards